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ABSTRACT 
 
 Male rat copulation is mediated by estrogen-sensitive neurons in the medial preoptic area 
(MPO) and medial amygdala (MEA); however, the mechanisms through which estradiol (E2) 
acts are not fully understood.  We hypothesized that E2 acts through estrogen receptor α (ERα) in 
the MPO and MEA to promote male mating behavior.  Antisense oligodeoxynucleotides (AS-
ODN) complementary to ERα mRNA were bilaterally infused via minipumps into either brain 
area to block the synthesis of ERα, which we predicted would reduce mating.  Western blot 
analysis and immunocytochemistry revealed a knockdown of ERα in each brain region; however, 
compared to saline controls, males receiving AS-ODN to the MPO showed significant reductions 
in all components of mating, whereas males receiving AS-ODN to the MEA continued to mate 
normally.  These results suggest that E2 acts differently in these brain regions to express sexual 
behavior and that ERα in the MPO, but not in the MEA, promotes mating. 
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INTRODUCTION 
 The central nervous system controls mating behavior by integrating both peripheral and 
central stimuli.  Sexual chemosensory, visual, auditory and somatosensory cues are received by 
the brain to promote expression of copulatory behavior, a process that is facilitated by gonadal 
steroids [Meisel and Sachs, 1994].  Testosterone (T) is released into circulation from the male 
testes, and their removal results in decreased sexual behavior [Beach and Holz-Tucker, 1949; 
Davidson, 1966].  Exogenous T, however, can restore mating behavior in long-term castrates or 
maintain mating if treatment is started at the time of castration [Davidson, 1966; Christensen and 
Clemens, 1974]. 
 In males, testicular T is irreversibly and extensively converted into several biologically 
active metabolites, including dihydrotestosterone (DHT) via 5α-reductase [Massa et al., 1972] 
and estradiol (E2) via aromatase [Naftolin et al., 1975], in both the periphery and the brain.  
Hormone manipulation studies have shown that these T metabolites, and T itself, contribute to 
the expression of mating behavior.  Studies showed that, unless dispensed at pharmacological 
doses, neither exogenous DHT [Feder, 1971; McGinnis and Dreifuss, 1989] nor E2 [Davidson, 
1969; Södersten, 1973] administered alone effectively restores mating behavior in castrated male 
rats.  However, administered together at physiological doses, DHT and E2 can fully restore or 
maintain mating behavior [Baum and Vreeburg, 1973; Larsson et al., 1973; Feder et al., 1974], 
as do physiological doses of T, suggesting that both androgenic and estrogenic metabolites of T 
promote male sexual behavior.  Significant reductions in mating behavior were observed in 
castrated, T-maintained male rats when the conversion of T to E2 was blocked by the 
administration of Fadrozole, a non-steroidal aromatase inhibitor [Vagell and McGinnis, 1997], 
either systemically [Bonsall et al., 1992] or locally into either the medial preoptic area (MPO) 
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[Clancy et al., 1995] or the medial amygdala (MEA) [Huddleston et al., 2006].  Additionally, 
these behavioral deficits were partially reversed by systemic E2 administration [Bonsall et al., 
1992] or local E2 implants into either the MPO [Clancy et al., 2000] or the MEA [Huddleston et 
al., 2003].  These studies suggest that the estrogenic metabolites of T contribute significantly to 
the normal expression of male copulatory behavior 
 Convergent evidence from behavioral changes following lesioning [Larsson and Heimer, 
1964; Harris and Sachs, 1975], electrophysiological stimulation [Malsbury, 1971; van Dis and 
Larsson, 1971], and hormone manipulation [Davidson, 1966a, 1966b; Davis and Barfield, 1979] 
studies suggest that a neuronal circuit composed of interconnected steroid-sensitive neurons 
forms the substrate that underlies male mating behavior and that key brain regions in this 
network include, but are not limited to, the MPO and the MEA.  Comparisons of Fos 
immunoreactivity (-ir) in the brains of mated males versus those of unmated controls revealed 
increased levels of Fos-ir in several brain regions, including the MPO and the MEA [Baum and 
Everitt, 1992; Coolen et al., 1996], indicating that these areas were active during mating.  Further 
studies revealed that neurons expressing mating-induced Fos-ir in the MPO and the MEA also 
contained either androgen receptors (AR), estrogen receptors (ER) or both AR and ER, 
suggesting that these brain regions are steroid sensitive [Greco et al., 1998]. 
 Although it is likely that E2-senitive neurons of the MPO and the MEA contribute to the 
expression of male rat sexual behavior, less is known about how E2 acts at the cellular level in 
either of these brain areas.  Both regions express ERα and ERβ [Shughrue and Merchenthaler, 
2001; Greco et al., 2003]; and, whereas knockout of ER can attenuate mating in male mice 
[Ogawa et al., 1997, 2000; Wersinger et al., 1997], a single ER subtype may have special 
behavioral significance in any given brain region.  Therefore, we sought to selectively remove 
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ERα from either the MPO or the MEA, hypothesizing that E2 acts through ERα in these two 
brain regions to promote mating.  To accomplish this, we infused either the MPO or the MEA 
with antisense oligodeoxynucleotides (AS-ODN) complementary to the translation start site of 
ERα mRNA. 
 The central dogma of molecular biology suggests that DNA is transcribed into RNA 
which is then translated into proteins.  AS-ODN are nucleic acid sequences designed to interact 
with mRNA transcripts according to Watson-Crick pairing rules, thus inhibiting their translations 
into proteins [Morris and Lucion, 1995; Landgraf, 1996].  In principle, any known gene sequence 
can be targeted, and its gene product intercepted, resulting in the down regulation of the protein 
product and, ultimately, a change in target cell function.  For example, ERα AS-ODN injected 
directly into the ventromedial hypothalamus (VMH) of neonates protected against the 
androgenizing effects of T in the developing female rat brain [McCarthy et al., 1993]; and, when 
injected into the right lateral ventricle of female rats, ERα AS-ODN resulted in decreased ERα-ir 
in the VMH and significantly reduced lordosis behavior [Walf et al., 2007].  Most in vivo studies 
have administered AS-ODN by acute injection into either the ventricles or specific sites in the 
brain, but very few studies have infused AS-ODN in a chronic manner into specific brain regions 
and into solid tissue, which was the approach employed in this study.  We chronically infused 
AS-ODN complementary to ERα mRNA into either the MPO or the MEA to test the hypothesis 
that ERα is the form of ER through which E2 acts in each of these brain regions for the display of 
mating behavior.  We predicted that AS-ODN infusion in the MPO or the MEA would block the 
local expression of ERα and reduce male rat copulatory behavior. 
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EXPERIMENTAL PROCEDURES 
Animals 
Male and female Sprague-Dawley rats, at least 65 days of age, were obtained from 
Charles River Laboratories.  Animals were housed in polycarbonate cages, 22 x 44 x 18 cm, on a 
14:10 hour reverse light:dark cycle (lights off at 0930 hours EST) with free access to food and 
water.  Males were housed two per cage until the day of surgery and were single housed 
thereafter.  Females were housed two per cage throughout the study.  All maintenance and 
surgical procedures were in accordance with institutional regulations and with the NIH Guide for 
the Care and Use of Laboratory Animals (NIH Publ. No. 85-23, revised 1985).   
Stimulus female rats were anesthetized by placing them in a chamber with an atmosphere 
of 5% isoflurane gas and an oxygen exchange rate of 1000 liters per minute (lpm) before 
transferring them to a nosecone dispensing 2% gas at 300 lpm.  Each female was ovariectomized 
and implanted subcutaneously (s.c.) with a 6 mm Silastic capsule filled with crystalline E2.  All 
females were allowed at least seven days to recover before the inception of behavioral testing.  
On test days, females received 1.0 mg progesterone (P) s.c. (1 mg P/0.2 ml sesame oil) 4-6 hours 
(h) before being paired with males.   
Male rats were screened for sexual behavior in four weekly 30 minute (min) mating tests 
to determine their suitability for inclusion in the study, and groups of proven maters were 
matched based on total ejaculation frequency.  These males were assigned to one of four groups:  
1. MPO AS-ODN (N = 6), 2. MPO SAL (N = 8), 3. MEA AS-ODN (N = 6) or 4. MEA SAL (N 
= 7).   
At the time of surgery, males were anesthetized using isoflurane gas in the same manner 
as the females.  Twenty-eight gauge stainless steel, ethylene oxide sterilized cannulae were 
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stereotaxically implanted bilaterally into either the MPO (level skull coordinates: a-p = -0.5 mm, 
m-l = ± 0.75 mm, d-v = -9.0 mm) or the MEA (level skull coordinates: a-p = -3.2 mm, m-l = ± 
3.5 mm, d-v = -9.2 mm) [Swanson, 1998].  Each cannula was connected via Tygon microbore 
tubing to an osmotic minipump (Alzet, model 2004) implanted s.c. in the scapular region.  
Minipumps infused either AS-ODN dissolved in physiological saline (AS-ODN groups) or 
physiological saline as a vehicle control (SAL groups) at the rate of 0.25 µl/hr (6 µl/day/cannula) 
for 28 days.  After a 5-7 day surgical recovery period, weekly 30 min sexual behavior tests 
resumed for a period of 8 weeks.  Minipumps were replaced under anesthesia following the 
fourth postoperative test.  Upon removal at week four and at the end of the study, the minipumps 
were examined to assure there were no pump failures; none occurred.   
 
Antisense Oligodeoxynucleotide Preparation 
Experimental animals were infused via minipumps with a 25-mer ODN sequence (5’-
GTGAAGGGTCATGGTCATGGTGAGT-3’) antisense to the translation start codon for rat ERα 
[Koike, 1987].  Lyophilized ODN (6290 µg, Oligos Etc. Inc., Wilsonville, OR) was re-suspended 
in 7.548 ml sterile physiological saline and stored in aliquots at -80°C until use.  These 
concentrated aliquots were further diluted before use to a working concentration of 1 µg AS-
ODN/12 µl saline, which was used to fill the pumps for the experimental animals (vehicle 
controls received minipumps containing saline only).  Before implantation, minipumps were 
incubated in sterile saline solution for 48 h at 37°C for priming.   
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Oligodeoxynucleotide Controls 
 Following behavioral screening, additional groups of matched males were formed for 
infusion of an ODN control.  In these groups, the MPO or MEA was infused with either a 
scrambled nucleotide sequence (SCRAM1:  5’ – CTCTACACATCGTGGATCGTGACTG – 3’, 
MPO N=5, MEA N=5; SCRAM2:  5’ – CTAGGTCTAGCTGTCCACACGTGAG – 3’, MPO 
N=7) or a missense nucleotide sequence (MIS:  5’ – GTGTAGGGTTATGGTCATTGTAAGT – 
3’, MPO N=9).  These altered sequences were not complementary to ER mRNA or any other 
known mRNA (GenBank nucleotide-nucleotide similarity BLAST search).  In contrast to the 
AS-ODN infused groups, a majority of the animals in these altered sequence groups were found 
to display brain morphological or behavioral abnormalities which resulted in death or required 
humane euthanasia.  Therefore, further attempts to develop this type of control were abandoned 
for ethical reasons. 
 
Male Sexual Behavior 
Behavior Testing Protocol 
During preoperative sexual screening and postoperative mating tests, each male was 
paired with a sexually receptive female for 30 min in a 22 x 44 x 50 cm testing arena under dim 
red light.  Tests began about 3 h after lights off.  The following behaviors were recorded by 
observers blind to the experimental status of the animals:  mount frequency (MF):  the number of 
mounts without penile penetration; intromission frequency (IF):  the number of mounts with 
penile penetration; and ejaculation frequency (EF):  the number of ejaculations.  We also 
measured mount latency (ML):  time from the beginning of the test until the first mount or 
intromission occurred or a default of 1800 sec if no mounts or intromissions occurred; 
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ejaculation latency (EL):  time from the first mount or intromission until the first ejaculation 
occurred or a default of 1800 sec if no ejaculations occurred; and the post-ejaculatory interval 
(PEI):  time between the first ejaculation and the next mount or intromission or a default of 1800 
sec if no ejaculation occurred.   
 
Tissue Collection 
Estrogen Receptor Immunocytochemistry and  Cannula Placement 
When the testing period was concluded, half of the males in each group were euthanized 
with an overdose of sodium pentobarbital (150 mg/kg i.p.) and perfused transcardially for 5 min 
with physiological saline followed by a minimum of 300 ml of a fixative containing 2% 
paraformaldehyde and 0.1% picric acid in 0.1 M phosphate buffer (PB) solution (pH 7.4).  Skulls 
were then partially opened and immersed overnight in the same perfusion fixative.  Brains were 
removed from skulls the next day and stored in 30% sucrose in 0.1 M PB for approximately 48 h.  
Frozen coronal brain sections (40 µm) through the diencephalon were collected into 0.1 M PB.  
One set of sections from each male was mounted on clean gel-albumin coated slides and stained 
with Toluine blue to verify cannula placement.  The remaining sections were stored in 
cryoprotectant (30% ethylene glycol, 20% glycerol, 50% 0.2 M PB, pH 7.4) at 4°C until used for 
immunocytochemistry (ICC). 
 
Western Blot Analysis 
 The remaining males in each group were euthanized with an overdose of sodium 
pentobarbital (150 mg/kg i.p.), and brains were quickly removed from the skulls and placed on 
an ice cold glass plate.  Two coronal razorblade cuts were made at the rostral and caudal 
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boundaries of the hypothalamus, anterior to the optic chiasm and posterior to the mammillary 
bodies, respectively, and the poles were discarded.  The slab containing the hypothalamus was 
divided coronally into two parts, a rostral piece containing the MPO and a caudal piece 
containing the MEA.  Bilateral parasaggital cuts at the medial edges of the left and right 
olfactory tubercules were made in the rostral slab containing the MPO, and the lateral edges of 
the slab were discarded.  Next, a horizontal cut was made ventral to the anterior commissure, and 
the dorsal piece was discarded; a saggital midline cut through the third ventricle divided the 
MPO into left and right halves.  In the caudal slab containing the MEA, a horizontal cut was 
made at the dorsal margin of the internal capsule, and the dorsal piece was discarded.  Next, 
bilateral parasaggital cuts were made at the medial edges of the left and right internal capsule, 
and the medial piece was discarded leaving two lateral tissue samples containing the left and 
right MEA.  Upon dissection, each sample was transferred immediately to an eppendorf tube and 
flash frozen in a methanol/dry ice bath.  All samples were stored at -80°C until used for protein 
isolation. 
 
Estrogen Receptor Immunocytochemistry 
Following a series of washes in 0.1 M PB to remove the cryoprotectant, coronal sections 
from animals in the four groups were processed concurrently with the same aliquots of 
antibodies and immunoreagents.  Sections were incubated with agitation, first, in a blocking 
solution containing 5% normal donkey serum (NDS) in 0.1 M PB (pH = 7.4) for 1 h at room 
temperature (RT) and, second, with the 1D5 anti-ER antibody (Zymed Laboratories, San 
Fransisco, CA, catalog # 18-7149) for 48 h at 4°C.  The 1D5 anti-ER antibody, a mouse 
monoclonal antibody whose epitope is located in the N-terminal domain (A/B region) of ER [al 
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Saati et al., 1993] and has been found to be specific for ERα [Tomanek et al., 1997; Nishihara et 
al., 2000], was used at a concentration of 0.75 µg/ml in a solution consisting of 5% NDS in 0.1 
M PB.  After three 5 min washes in 0.1 M PB, sections were then incubated for 2 h RT with a 
donkey anti-mouse biotinylated secondary antibody (Jackson Laboratories, Bar Harbor, ME, 
code # 715-065-151, lot # 48672) at a dilution of 1:200 in 0.1 M PB plus 3% NDS.  Sections 
were then washed in three 5 min changes of 0.1 M PB and incubated for 1 h RT in an avidin-
biotinylated peroxidase complex (Vector Labs, Burlingame, CA, Vectastain Elite Standard ABC 
kit, catalog # PK-6100, A and B reagents prepared at one-tenth the manufacture’s recommended 
concentration).  Following three additional 5 min washes in 0.1 M PB, the sections were 
incubated for 20 min RT in a solution containing 0.2 mg/ml diaminobenzidine (Sigma-Aldrich, 
St. Louis, MO, catalog # D-5637, lot # 29H1060) plus 0.1 µl/ml 30% H2O2 (Sigma-Aldrich, St. 
Louis, MO, catalog # H-1009, lot # 014K3646) dissolved in 0.1 M PB.   
 
Western Blot Analysis 
Protein Isolation 
 Within each experimental group (MPO AS-ODN (N=2), MPO SAL (N=2), MEA AS-
ODN (N=2), and MEA SAL (N=2)), tissue samples from the left side of the brain were pooled 
and homogenized in 1ml Hepes buffer solution (5 mM Hepes, .3 mM EDTA) with a protease 
inhibitor cocktail additive (Sigma-Aldrich, St. Louis, MO, catalog #P8340).  The homogenates 
were centrifuged for 25 min at 4°C at 18,200 x g.  The supernatant was immediately removed 
and stored at -80°C until use.  The protein concentration for each sample was later determined by 
a bicinchoninic acid assay (Pierce, Rockford, IL, catalog #23227). 
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Western Blot 
 Ten µg of protein from each sample were run on a 10% Tris-HCl gel (Bio-Rad, Hercules, 
CA) and transferred to polyvinylidene fluoride membrane (Bio-Rad, Hercules, CA, catalog 
#162-0180).  The membrane was blocked in 5% nonfat dry milk (NDM) in Tween-Tris buffered 
saline (TTBS) for 4 h and incubated overnight at 4°C in 1D5 (1:500 in 2% NDM in TTBS).  
Following a series of washes in TTBS, the membrane was incubated at room temperature for 1 h 
in a horseradish peroxidase linked anti-mouse secondary antibody (1:2000 in 2% NDM in TTBS; 
Cell Signaling Technology Inc, Danvers, MA, catalog #7076) and was visualized using 
LumiGLO Chemiluminescent Substrate (Upstate, Lake Placid, NY, catalog #20-212) on Kodak 
Biomax light film (Sigma-Aldrich, St. Louis, MO, catalog #Z370371-50EA, Kodak #178 8207). 
 
Quantification of Western Blot 
Film from the western blot was scanned directly, and the relative optical density (OD) 
was measured microscopically using Bioquant software (BQ-TCW98, version 3.50.6 MT, R&M 
Biometrics, Nashville, TN).  Fields in the center of each band (750µm x 550µm; 281,805 pixels) 
were measured under identical conditions of illumination, thresholding on dark pixels (R=92.0; 
G=94.0; B=86.0) in the darkest field which yielded an optical density value for each band in the 
western blot. 
 
Statistics 
 Between-group behavioral data were analyzed by repeated measures (group by trial) 
analysis of variance, followed by post hoc comparisons using the Tukey honestly significant 
differences test at a probability level of 0.05, whereas within-group comparisons of preoperative 
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and postoperative changes in behavior were analyzed by paired t-tests [Kirk, 1968].  The Mann-
Whitney U [Siegel, 1956] test was used to analyze ICC data.  Two-tailed probabilities are 
reported except if explicitly stated otherwise. 
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RESULTS 
Male Sexual Behavior 
 Highly significant group differences emerged during the postoperative period in which 
animals that had been infused into the MPO with AS-ODN virtually ceased mating, whereas the 
animals in the other 3 groups exhibited robust mating, as indicated by all behavioral indices 
(FIGURE 1).  Specifically, during postoperative trials, the 4 groups differed significantly in 
mount frequency (group main effect:  F3,23 = 10.20, p < 0.001, trial main effect F7,161 = 2.13, p < 
0.043), intromission frequency (group main effect:  F3,23 = 15.47, p < 0.001), ejaculation 
frequency (group main effect:  F3,23 = 6.48, p < 0.003), mount latency (group main effect:  F3,23 = 
6.92, p < 0.002, trial main effect F7,161 = 2.75, p < 0.01), ejaculation latency (group main effect:  
F3,23 = 8.23, p < 0.001) and the post-ejaculatory interval (group main effect:  F3,23 = 13.48, p < 
0.001).  Prior to surgery, however, the animals in all 4 groups had mated robustly and the groups 
were statistically indistinguishable on intromission frequency, ejaculation frequency and the 
post-ejaculatory interval, although some modest but significant differences were noted on mount 
frequency (group x trial interaction:  F9,69 = 2.07, p < 0.044), mount latency (group x trial 
interaction:  F9,69 = 2.49, p < 0.016) and ejaculation latency (group x trial interaction:  F9,69 = 
2.02, p < 0.049).  Thus, group differences manifested during the postoperative trials.   
 In a follow-up analysis, because post hoc pairwise comparisons indicated that MPO SAL, 
MEA AS-ODN and MEA SAL groups were statistically indistinguishable on all indices of 
copulatory behavior during all postoperative trials, these 3 groups were pooled; and the sexual 
performance of this combined control group was subsequently compared with that of animals in 
the MPO AS-ODN group.  Infusion of the MPO with AS-ODN profoundly suppressed mating 
behavior in comparison to that of the combined control group.  Specifically, during postoperative  
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FIGURE 1:  MALE SEXUAL BEHAVIOR.  Preoperative and postoperative mating behaviors (mean ± standard 
error) of all groups.  Males infused with saline to the MPO or MEA mated normally, as did males infused with AS-
ODN to the MEA; whereas, males receiving AS-ODN to the MPO virtually ceased mating.  Blackened symbols 
indicate the trials where post hoc group comparisons revealed that the MPO AS-ODN group differed significantly 
from the other groups (p < 0.05, two-tailed).  Asterisks (*) indicate behaviors in which the within group comparison 
of preoperative trials and terminal postoperative performance differed significantly (see text). 
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trials, the 2 groups differed significantly in mount frequency (group main effect:  F1,25 = 32.60, p 
< 0.001; trial main effect:  F7,175 = 2.11, p < 0.040), intromission frequency (group main effect:  
F1,25 = 46.94, p < 0.001; trial main effect:  F7,175 = 2.07, p < 0.049; group x trial interaction:  
F7,175 = 3.02, p < 0.005), ejaculation frequency (group main effect:  F1,25 = 12.85, p < 0.002), 
mount latency (group main effect:  F1,25 = 15.21, p < 0.001; trial main effect:  F7,175 = 2.73, p < 
0.010; group x trial interaction:  F7,175 = 2.38, p < 0.024), ejaculation latency (group main effect:  
F1,25 = 21.31, p < 0.001) and the post-ejaculatory interval (group main effect:  F1,25 = 39.45, p < 
0.001; trial main effect:  F7,175 = 2.72, p < 0.011).  Subsequently, post hoc group comparisons 
indicated significant differences (p < 0.05) in mount frequency on trials 2, 3, 4, 5, 7 and 8, 
intromission frequency on all trials but the first, ejaculation frequency on trials 3 and 5, mount 
latency on trials 3, 5, 6 and 7, ejaculation latency on trials 3, 5 and 6 and the post-ejaculatory 
interval on all trials but the first.   
In the MPO AS-ODN group, for each dependent variable, there was a significant decline 
in sexual performance between the preoperative and postoperative periods.  Specifically, for 
mount frequency, comparisons of preoperative performance (averaged over 4 preoperative trials) 
with postoperative performance (averaged over the last 4 postoperative trials, which represents 
terminal postoperative performance) indicated that mounting declined significantly in frequency 
during the postoperative period (t = 3.18, df = 5, p < 0.025).  Similarly, comparisons of the same 
sets of trials indicated that intromission frequency declined significantly during the postoperative 
period (t = 5.37, df = 5, p < 0.003), as did ejaculation frequency (t = 2.68, df = 5, p < 0.044), 
whereas mount latency (t = 2. 79, df = 5, p < 0.038), ejaculation latency (t = 3.10, df = 5, p < 
0.027) and the post-ejaculatory interval (t = 3.57, df = 5, p < 0.016) increased significantly.  In 
marked contrast to the deterioration of mating that occurred in the MPO AS-ODN group, there 
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were no significant changes on any behavioral measure between preoperative and postoperative 
periods in the MPO SAL (infused with saline to the MPO), and MEA AS-ODN (infused with 
AS-ODN to the MEA) groups.  In the MEA SAL group (infused with saline to the MEA), except 
that intromission frequency was significantly lower postoperatively than preoperatively (t = 
4.15,df = 6, p < 0.006), the animals in this group also exhibited robust mating both before and 
after surgery, and no other behavioral measures differed significantly between the preoperative 
and postoperative periods.  
 
Estrogen Receptor Immunocytochemistry 
Chronic AS-ODN infusion inhibited ERα expression as assessed by ERα ICC.  Infusion 
of the MPO (FIGURE 2) or MEA (FIGURE 3) with AS-ODN suppressed ERα-ir neuronal 
labeling in the MPO or MEA, respectively; whereas, saline infusion of either brain area was 
accompanied by appreciable ERα-ir labeling.  Specifically, significantly fewer ERα-ir neurons 
were detected in the MPO of rats in the MPO AS-ODN group (mean ± standard error:  4.88 ± 
3.18) than were found in the MPO of rats in the MPO SAL group (20.88 ± 2.83), U = 1, n1 = 5, 
n2 = 3, p < 0.036, 1-tail.  Moreover, significantly fewer ERα-ir neurons were detected in the 
MEA of rats in the MEA AS-ODN group (0.00 ± 0.00) than were found in the MEA of rats in 
the MEA SAL group (12.79 ± 5.70), U = 0, n1 = 4, n2 = 4, p < 0.028.  No significant differences 
in ERα-ir neuronal counts were detected in the arcuate nucleus of either the MPO AS-ODN and 
MPO SAL groups (33.99 ± 10.46 and 29.17 ± 12.50, respectively, p > 0.05) or the MEA AS-
ODN and MEA SAL groups (30.54 ± 9.32 and 58.33 ± 11.14, respectively, p > 0.05). 
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FIGURE 2:  ESTROGEN RECEPTOR IMMUNOCYTOCHEMISTRYIN THE MPO.  Sections through the 
MPO (top row) and ARC (bottom row) from males in the MPO AS-ODN (left column) and MPO SAL (right 
column) groups were processed concurrently with the 1D5 anti-ERα antibody.  ERα-ir labeling was reduced 
significantly (see text) in the MPO of males in the MPO AS-ODN group as compared to the MPO of males in the 
MPO SAL group.  Abundant ERα-ir labeling occurred in the ARC in both cases suggesting that infusion of the AS-
ODN blocked expression of ERα in the MPO only. 
ARC ARC
MPO MPO
AS-ODN SALINE 
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FIGURE 3:  ESTROGEN RECEPTOR IMMUNOCYTOCHEMISTRYIN THE MEA.  Sections through the 
MEA (top row) and ARC (bottom row) from males in the MEA AS-ODN (left column) and MEA SAL (right 
column) groups were processed concurrently with the 1D5 anti-ERα antibody.  ERα-ir labeling was reduced 
significantly (see text) in the MEA of males in the MEA AS-ODN group as compared to the MEA of males in the 
MEA SAL group.  Abundant ERα-ir labeling occurred in the ARC in both cases suggesting that infusion of the AS-
ODN blocked expression of ERα in the MEA only. 
MEA MEA
ARC ARC
AS-ODN SALINE 
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Western Blot Analysis 
The 1D5 antibody recognized protein bands at approximately 67 kDa, which is the 
previously reported size for full length rat ERα [Koike et al., 1987; Furlow et al., 1990].  The 
band corresponding to the MPO SAL group was darkest suggesting an appreciable concentration 
of ERα in the MPO; whereas, the band associated with the MPO AS-ODN group was 
substantially lighter.  Quantification of the western blot indicated an approximate 4-fold 
knockdown of ERα by AS-ODN infusion of the MPO (FIGURE 4).  Although overall ERα 
expression was lower in the MEA as compared to the MPO, similar results were observed in the 
MEA in which quantification of the western blot revealed an approximate 6-fold knockdown of 
ERα by AS-ODN infusion of the MEA (FIGURE 4).  These results are consistent with those 
obtained from ERα ICC. 
 
Cannula Placements 
Locations of cannula placements to the MPO are indicated in FIGURE 5 and those to the 
MEA in FIGURE 6 (see Tissue Collection in Experimental Procedures).  Cannula tips were 
positioned in or near the MPO or MEA in all groups of animals. 
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FIGURE 4:  RELATIVE OPTICAL DENSITY OF WESTERN BLOT ANAYSIS.  Relative optical density was 
measured for each band found at 67kDa in the western blot, and expressed as a percentage based on the total pixel 
count in the field evaluated.  The bands corresponding to the SAL groups in both the MPO and the MEA contained 
the highest percentage of dark pixels (50.24% and 22.14%, respectively); whereas, bands corresponding to the AS-
ODN groups in both the MPO and the MEA contained fewer dark pixels (13.18% and 3.79%, respectively) 
suggesting that AS-ODN infusion blocked expression of ERα in both brain regions.  Fields sampled within the 
bands are pictured below the bars for each group. 
20 
 
 
 
FIGURE 5:  CANNULA PLACEMENTS TO THE MPO.  Cannula tips were positioned in or near the MPO in 
the MPO AS-ODN and MPO SAL groups. 
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FIGURE 6:  CANNULA PLACEMENTS TO THE MEA.  Cannula tips were positioned in or near the MEA in 
the MEA AS-ODN groups and the MEA SAL groups. 
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DISCUSSION 
 Chronic bilateral infusion of an AS-ODN complementary to the translation start site of 
ERα mRNA into the MPO of gonadally intact male rats locally reduced the level of ERα in the 
MPO and suppressed mating behavior.  Identical AS-ODN infusion into the MEA also locally 
reduced ERα levels but did not impair mating.  Males infused with saline into either brain area 
mated robustly and had higher levels of ERα in comparison to those infused with AS-ODN.  
Specifically, in comparison to pretreatment levels of mating behavior and to the postoperative 
performance of control males, animals infused with AS-ODN in the MPO showed significant 
reductions in the number of mounts, intromissions, and ejaculations; whereas, males infused with 
AS-ODN in the MEA continued to mate normally. 
 This study tested the hypothesis that E2 acts through ERα in the MPO and the MEA to 
promote mating behavior.  We predicted that chronic infusion of an AS-ODN complementary to 
ERα mRNA into either of these brain areas would knock down ERα expression in a site-specific 
manner in the MPO or the MEA and reduce mating.  The hypothesis was only partially 
supported.  Western blot analysis revealed a knock down of ERα proteins in both the MPO AS-
ODN and MEA AS-ODN groups (as compared to the MPO SAL and MEA SAL groups) by 
approximately 4- and 6-fold, respectively.  ERα ICC showed significantly reduced ERα-ir 
labeling in both the MPO and the MEA in males treated with AS-ODN as compared to those 
treated with saline in the same brain regions.  The western blot analysis and ICC results are 
mutually reinforcing, suggesting that chronic infusion of the AS-ODN inhibited ERα expression 
in a site-specific manner in both the MPO and the MEA.  Copulatory behavior was suppressed 
by MPO AS-ODN infusion, but not MEA AS-ODN infusion, where mating remained robust, 
indicating that the behavioral effects of the AS-ODN in the MPO must be attributed to the 
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specific effect of ERα reduction rather than to a non-specific, toxic effect of AS-ODN treatment.  
Additionally, because in this study we selectively disabled ERα production in the MPO or the 
MEA of gonadally intact male rats, it is likely that in the MPO and the MEA all remaining non-
ERα steroid receptors were present and were exposed to naturally produced hormones in a 
physiologically relevant manner.  Taken together, these results suggest that ERα mediates the 
responses of the MPO to E2 that are critical for mating behavior; whereas, ERα is not necessary 
in the MEA for sexual behavior to occur, and a different, non-ERα form of ER mediates the 
mating response to E2 in the MEA.  Thus, E2 appears to exert its actions differently in the MPO 
and the MEA.   
 Previous research showed that E2 must act in the MPO [Clancy et al., 1995, 2000] and the 
MEA [Huddleston et al., 2003, 2006] for robust mating behavior to occur, and ERα has been 
reported to be the form of ER that is important for expression of mating [Rissman et al., 1997; 
Ogawa et al., 1998].  Physiological doses of either exogenous T or a combination of its 
androgenic and estrogenic metabolites, DHT and E2 respectively, maintain or restore sexual 
behavior in castrated male rats [Baum and Vreeburg, 1973; Larsson et al., 1973; Feder et al., 
1974].  These studies are reinforced by additional findings with aromatase knockout (ArKO) 
mice in which ArKO males exhibited significantly reduced mating behavior [Matsumoto et al., 
2003; Bakker et al., 2004] that was partially reversed by daily injections of either E2 or E2+DHT 
[Bakker et al., 2004]; however, these mouse studies do not address where specifically E2 acts in 
the brain.  Blocking the conversion of T to E2 by site-specific infusion of the aromatase inhibitor 
Fadrozole in either the MPO [Clancy et al., 1995] or the MEA [Huddleston et al., 2006] 
decreases the sexual behavior of gonadally intact male rats; and, E2 implants to either the MPO 
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[Clancy et al., 2000] or the MEA [Huddleston et al., 2003] maintain mating behavior of intact 
male rats receiving systemic Fadrozole.   
 While it is clear that E2 acts in the MPO and the MEA to promote mating behavior in 
male rats, the receptor and cellular mechanisms underlying the response to E2 and how they 
contribute to male mating behavior are less well-understood.  Presumably, most, if not all, of 
E2’s actions are initiated through ER.  However, the discovery of multiple ER subtypes [Kuiper 
et al., 1996; Thomas et al., 2005; Toran-Allerand, et al., 2002] raised questions as to which ER 
subtype(s) mediate mating and whether the numerous brain areas that contribute to sexual 
behavior use E2 in an identical manner.  Traditionally, it was thought that E2 action was mediated 
by a single type of ER found within either the nuclear envelope [King and Greene, 1984] or the 
cytoplasm [Blaustein, 1992] of E2-responsive cells.  In 1996, a novel ER (now termed ERβ) was 
characterized that shared with the known ER (now termed ERα) both a high degree of sequence 
homology in the DNA (95%) and ligand (55%) binding domains (DBD and LBD, respectively) 
and similar affinities for most estrogenic and antiestrogenic substances [Kuiper et al., 1996, 
1997].  Additionally, both ER subtypes exhibit similar transactivation properties, including a 
comparable ligand independent activation function 1 (AF-1) in the N-terminal region sensitive to 
the mitogen-activated protein kinase (MAPK) pathway [Kato et al., 1995; Tremblay et al., 1997] 
and a second ligand dependent activation function (AF-2) in the LBD that is enhanced by 
binding of coactivators, such as steroid receptor coactivator 1 (SRC-1) [White et al., 1997].  
Interestingly, it has been reported that when gene transcription depends on both activation 
functions, activity of AF-1 in ERβ is negligible in the presence of ERα and that ERα activity 
dominates; however, if AF-1 is not required, the transcriptional activities supported by AF-2 of 
ERα and ERβ are similar [Cowley and Parker, 1999]; this may influence differential selective 
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transcription in brain areas expressing different levels of ER subtypes.  Studies in female rats 
revealed differences in regional brain distribution of both ER subtypes and showed that brain 
regions implicated in the expression of mating behavior, including the MPO and the MEA, 
expressed both ERα and ERβ mRNA [Shughrue et al., 1997] and receptor proteins [Shughrue 
and Merchenthaler, 2001; Gréco et al., 2003]; moreover, levels of each receptor subtype also 
varied in subregional expression within individual brain areas further enhancing the regulatory 
potential of E2. 
 Following E2 binding, ERs form either homodimers [Kumar and Chambon, 1988] when a 
single ER subtype is present or both homo- and heterodimers [Cowley et al., 1997; Pettersson et 
al., 1997] in the presence of both ERα and ERβ.  These dimers may then act in either a classical 
manner, directly interacting with various estrogen response elements on the DNA of target genes 
to initiate transcription [Cowley et al., 1997; Pettersson et al., 1997; Tamrazi et al., 2002], or a 
nonclassical manner, involving protein-protein interactions with other transcription factor 
complexes bound to their response elements, such as activator protein 1 (AP-1), to indirectly 
initiate gene transcription [Jakacka et al., 2001].  Interestingly, nonclassical binding of ER in the 
AP-1 pathway resulted in transcription activation by ERα and transcription inhibition by ERβ 
[Paech et al., 1997; Jakacka et al., 2001], further suggesting that E2’s actions may be modulated 
based on levels of ER subtypes present in target cells.   
 Rapid effects of E2 have been shown to be mediated via ER located on intracellular 
membranes [Revankar et al., 2005] or the plasma membrane [Razandi et al., 1999; Wade et al., 
2001].  Although a membrane receptor has yet to be isolated and characterized, in vitro studies 
indicate that membrane ER exist and are isoforms of distinct nuclear ERα and ERβ transcripts 
[Razandi et al., 1999, 2004].  In contrast, membrane actions of E2 have also been described that 
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are mediated by receptors unrelated to nuclear ER, mainly involving transduction via G-protein 
coupled mechanisms and activation of secondary signaling cascades which may or may not 
result in gene transcription [Nadal et al., 2000; Qui et al., 2003; Thomas et al., 2005].  Due to the 
complexities in defining the mechanisms of E2 action, studies must be carefully structured to 
determine which ER form mediates any particular behavior, where the receptors are located on 
the target cells, and what the cellular consequences are when E2 binds the receptor.  The results 
from this study, together with recent reports, allow us to begin to answer these questions. 
 Both ERα-ir and ERβ-ir neurons occur in the rat MPO and MEA [Shughrue and 
Merchenthaler, 2001] and each region colocalizes mating induced Fos-ir [Gréco et al., 2003], 
suggesting that either ER subtype may contribute to mating behavior.  Studies using estrogen 
receptor knockout (ERKO) mice suggest, however, that ERα is the form of ER that mediates 
copulatory behavior.  Specifically, in gonadally intact mice lacking the ERα gene (αERKO), 
males show reduced intromission and no ejaculatory behaviors in comparison to wild type (WT) 
and heterozygous males [Ogawa et al., 1997]; whereas, other studies [Wersinger et al., 1997; 
Rissman et al., 1997, 1999] observed significant reductions in all components of copulatory 
behavior.  In castrated αERKO male mice, androgen replacement did not restore the ejaculatory 
component of mating behavior, suggesting that ERα is important in the consummatory aspect of 
mating behavior [Ogawa et al., 1998].  In contrast to αERKO studies, observations in mice 
lacking the ERβ gene (βERKO) revealed few if any differences in the expression of sexual 
behaviors compared to WT mice [Ogawa et al., 1999], reinforcing the importance of ERα in the 
facilitation of male mating behavior.  Nevertheless, male mice with a double knockout for both 
the ERα and ERβ genes (αβERKO) displayed no reproductive behaviors at all [Ogawa et al., 
2000].  Together, these findings suggest a major role for ERα and a minor role for ERβ in the 
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regulation of male mating behavior.  However, there are limitations to these reports.  For 
example, studies showed increased levels of circulating sex hormones in ERKO mice [Eddy et 
al., 1996; Rissman et al., 1997], suggesting that knockout of a gene may result in second order 
effects.  Findings by Apostolakis et al. [2002] suggest the possibility that activation of a 
secondary, compensatory system may mask the effects of total gene deletion.  Questions also 
arise as to whether the observed effects are because the targeted gene product was unavailable 
during development or because it was unavailable during adulthood; and, most importantly, 
knockout studies do not tell us where in the brain gene inactivation is having its effect.  Our use 
of antisense technology removes some of these difficulties because it allows for site-specific 
knockdown of a gene product during a restricted time periods rather than total ablation of the 
gene in the whole system. 
 We predicted that AS-ODN treatment to either the MPO or the MEA would attenuate 
sexual behavior, but copulation was significantly reduced by AS-ODN infusion of the MPO 
only; blockade of ERα expression in the MEA did not affect mating behavior.  Moreover, 
reducing expression of ERα in the MPO significantly reduced all components of reproductive 
behavior, suggesting that ERα is necessary in the MPO for the expression of male rat sexual 
behavior.  It is less clear which ER subtype is required in the MEA for mating, but these results 
suggest that ERα is not necessary in the MEA for male rat copulation to occur.  These findings 
complement reports in female rats, in which mating-induced Fos-ir in the MPO was primarily 
coexpressed with cells that contained either ERα alone or both ERα and ERβ; whereas, in the 
MEA, mating induced Fos-ir was primarily coexpressed with cells that contained either ERβ 
alone or both receptor types [Gréco et al., 2003].  Together, these reports suggest that ERβ may 
mediate E2 responses required for mating in the MEA. 
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 Although the present study does not address where ER are located on the target cells or 
what cellular mechanisms are employed for E2 to exert its effects, studies using E2 conjugated to 
bovine serum albumin (BSA-E2), a large protein shown not to cross the plasma membrane thus 
restricting E2 actions to the cell surface [Huddleston et al., 2007], are beginning to address these 
questions.  Specifically, castrated DHT-maintained male rats receiving BSA-E2 implants into the 
MPO mated normally [Huddleston et al., 2007]; whereas, males receiving BSA-E2 implants into 
the MEA exhibited reduced sexual behavior [Huddleston et al., 2006].  These results suggest that 
a cell surface action of E2 in the MPO is sufficient for the expression of mating behavior and, 
when combined with the present findings, suggest that this action occurs via an ERα protein 
associated with the plasma membrane, reinforcing that E2 acts differently in the MPO than in the 
MEA. 
 The present findings help to delineate which ER subtypes are required in different areas 
of the brain where E2 acts.  Our findings suggest that, in the MPO, ERα is necessary for the 
expression of mating behavior; whereas, ERα is not necessary in the MEA for the expression of 
sexual behavior, suggesting that another ER subtype, perhaps ERβ, is important in the MEA.  
Thus, E2 acts differently in different brain regions to mediate the expression of male rat 
copulatory behavior. 
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